
Blog
Potentiating adoptive cell therapy using synthetic IL-9 receptors
Researchers have shown that a synthetic IL-9 receptor allows anti-cancer
Researchers have shown that a synthetic IL-9 receptor allows anti-cancer
A major drawback of CRISPR-Cas9-mediated genome editing is that not
Genetically modified immune cells successfully target specific cancer cells that
Breakthrough findings were presented at the 2022 ASCO Annual Meeting
It is a pity that non integrating lentiviral vectors are
In a recent study, a team of researchers used a
With a $17 million grant, UCSF Benioff Children’s Hospital in
The FDA has granted accelerated designation to PRGN-3006 for the
Mucopolysaccharidosis I is caused by mutations in the gene for